BioMedomics will be at ASCAT 2025, London, UK
September 17, 2025
📍 Booth #3 | Excel London | October 1–4, 2025 Join BioMedomics at the 20th Annual ASCAT Conference — the leading global event focused on
Latest News
-
September 17, 2025 BioMedomics will be at ASCAT 2025, London, UK
- June 2, 2025
BioMedomics will be a sponsor of the 5th Global Congress on Sickle Cell Disease
- December 16, 2024
Sickle SCAN® EZ: Empowering Large-Scale Sickle Cell Diagnostics with Cutting-Edge Simplicity
- June 12, 2024
BioMedomics Announces Grants , Starting on June 19th, 2024,the world Sickle Cell Day, to Advance Sickle Cell Disease Testing in Sub-Saharan Africa
- February 23, 2024
BioMedomics, Inc. Recertified for ISO 13485
Learn More
BioMedomics will be a sponsor of the 5th Global Congress on Sickle Cell Disease
June 2, 2025
BioMedomics will be a sponsor of the 5th Global Congress on Sickle Cell Disease in Abuja, Nigeria between June 3rd and 6th June.
Sickle SCAN® EZ: Empowering Large-Scale Sickle Cell Diagnostics with Cutting-Edge Simplicity
December 16, 2024
Facilitating Sickle Cell Disease Diagnostics with Sickle SCAN EZ BioMedomics revolutionized diagnostics for Sickle Cell Disease (SCD) and Sickle Cell Trait (SCT) with Sickle SCAN®,
BioMedomics Announces Grants , Starting on June 19th, 2024,the world Sickle Cell Day, to Advance Sickle Cell Disease Testing in Sub-Saharan Africa
June 12, 2024
BioMedomics, the manufacturer of Sickle SCAN, the world’s first Point of Care rapid test for Sickle Cell Disease (SCD), is excited to announce a Request
BioMedomics, Inc. Recertified for ISO 13485
February 23, 2024
BioMedomics, Inc. is proud to announce that the BSI Group of America has accredited and recertified our ISO 13485:2016 certification. The certification of compliance with
Saudi FDA Approval Announcement
December 30, 2022
BioMedomics is an ISO 13485 certified company committed to meeting unmet market needs by developing innovative point-of-care diagnostic tests which provide immediate answers to individuals
BioMedomics Celebrates Sickle Cell Awareness Month
September 15, 2021
BioMedomics, Inc. is proud to announce that the BSI Group of America has accredited and recertified our ISO 13485:2016 certification. The certification of compliance with
BioMedomics, Inc. Recertified for ISO 13485
August 27, 2021
BioMedomics, Inc. is proud to announce that the BSI Group of America has accredited and recertified our ISO 13485:2016 certification. The certification of compliance with
BioMedomics, Inc.’s ISO 13485 Certification Granted Expansion
January 6, 2021
BioMedomics, Inc. is proud to announce its ISO 13485:2016 certificate has expanded in scope to include the design, development and manufacturing of COVID-19 rapid tests.
Sickle SCAN® Approved by Department of Health in Australia!
September 3, 2020
We are excited to announce that the Therapeutic Goods Administration, a branch of the Department of Health in the Australian Government, has given BioMedomics, Inc.